Dr. Kelley Kozma, DO

Dr. Kozma practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Dr. Kozma's NPI, 1518168202, was assigned on May 30, 2007. Dr. Kozma graduated from Michigan State University College Of Osteopathic Medicine in 2007. Dr. Kozma holds Florida license OS19848.

Dr. Kozma's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Dr. Kozma's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Kozma to 1 more group practice or clinic, named with a free account. Dr. Kozma's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kozma practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kozma's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kozma is board certified in hematology by the American Board of Internal Medicine. Dr. Kozma is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Kozma treats.

CMS data shows 815 Medicare services from Dr. Kozma across 8 procedure codes in 2024, for 292 Medicare patients. Medicare paid $70,644 for them.

CMS counts 292 Medicare patients who saw Dr. Kozma in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kozma's median patient age at 70, with 67% women.

In 2024, Dr. Kozma wrote 708 Medicare Part D claims for 212 patients. 86% of them were for generic drugs. CMS names the drug for 448 of them, across 12 drugs with 11 or more claims each, at $8,472 in total drug cost. In 2023, CMS named 339 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Kozma for performance year 2024, reported through an alternative payment model (APM). Dr. Kozma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kozma as offering telehealth.

Dmand AI links 2 papers to Dr. Kozma in 2019. Dr. Kozma's most frequent co-authors are Taha Alrifai, MD, Sarbagya Pandit, MD and Raya Saba, MD.

CMS Open Payments shows 23 general payments to Dr. Kozma from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Janssen Pharmaceuticals, Inc paid the most, $238.

Dr. Kozma graduated from Michigan State University College Of Osteopathic Medicine in 2007.

Dr. Kozma is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.